Uhlmann Price Securities LLC Takes Position in CME Group Inc. $CME

Uhlmann Price Securities LLC purchased a new stake in shares of CME Group Inc. (NASDAQ:CME) during the 3rd quarter, Holdings Channel reports. The fund purchased 2,655 shares of the financial services provider’s stock, valued at approximately $717,000.

Several other hedge funds have also recently bought and sold shares of CME. Caldwell Trust Co increased its holdings in shares of CME Group by 116.3% in the 3rd quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 50 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new stake in shares of CME Group during the third quarter worth approximately $27,000. Financial Consulate Inc. purchased a new position in CME Group during the third quarter valued at approximately $28,000. Sagard Holdings Management Inc. acquired a new position in CME Group in the 2nd quarter valued at approximately $30,000. Finally, Corundum Trust Company INC acquired a new position in CME Group in the 3rd quarter valued at approximately $30,000. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Trading Up 0.5%

NASDAQ:CME opened at $303.07 on Friday. The company’s 50 day moving average is $279.82 and its 200-day moving average is $274.00. The company has a quick ratio of 1.02, a current ratio of 1.03 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 12 month low of $244.43 and a 12 month high of $309.35. The firm has a market cap of $109.29 billion, a price-to-earnings ratio of 27.16, a P/E/G ratio of 3.30 and a beta of 0.27.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.75 by $0.02. The business had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.64 billion. CME Group had a net margin of 62.45% and a return on equity of 14.65%. CME Group’s revenue was up 8.1% compared to the same quarter last year. During the same period last year, the business posted $2.52 EPS. Equities analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 26th. Stockholders of record on Tuesday, March 10th will be paid a $1.30 dividend. The ex-dividend date is Tuesday, March 10th. This is a boost from CME Group’s previous quarterly dividend of $1.25. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.7%. CME Group’s dividend payout ratio is presently 44.80%.

Insider Buying and Selling

In related news, CEO Terrence A. Duffy sold 25,000 shares of the stock in a transaction that occurred on Thursday, December 11th. The stock was sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the completion of the sale, the chief executive officer owned 65,804 shares in the company, valued at $17,737,468.20. This represents a 27.53% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Dennis Suskind sold 748 shares of the firm’s stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $300.00, for a total value of $224,400.00. Following the completion of the sale, the director directly owned 2,699 shares in the company, valued at $809,700. This trade represents a 21.70% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is owned by insiders.

Key Headlines Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME raised shareholder payouts — the board declared a Q1 quarterly dividend of $1.30 (up from $1.25) and an annual variable dividend of $6.15 based on 2025 results (total ≈ $2.2B), both payable March 26; that boosts cash return to investors. CME Group Declares Annual Variable Dividend and Q1 2026 Quarterly Dividend
• Positive Sentiment: Analyst price-target lift — Rothschild & Co Redburn raised its CME price target to $333 from $300 (still a “neutral” rating), implying roughly 9.7% upside versus recent levels, which can support buying interest. Rothschild & Co Redburn Adjusts Price Target on CME Group to $333 From $300, Maintains Neutral Rating
• Positive Sentiment: New product rollout and execution — CME reported first trades in new Cardano, Chainlink and Stellar crypto futures and is actively exploring a rare-earths futures contract; these product additions expand fee pools and diversify revenue. CME Group Announces First Trades for New Cardano, Chainlink and Stellar Cryptocurrency Futures CME Weighs Launching First-Ever Rare Earth Futures Contract / Reuters
• Positive Sentiment: Asia expansion — reports say CME plans to list Taiwan and Hong Kong warehouses for aluminium futures in Asia, a move that could deepen regional market presence and increase volumes. Exclusive: CME to list Taiwan, Hong Kong warehouses in Asia aluminium push, sources say
• Neutral Sentiment: CFTC advisory involvement — the CFTC formed an Innovation Advisory Committee that includes a CME executive; this provides regulatory engagement but unclear near-term financial impact. CFTC Forms Innovation Advisory Committee With 35 Crypto and Finance Industry Leaders
• Neutral Sentiment: Board slate announced — CME named director nominees for the annual meeting; routine governance news that is unlikely to move the stock materially. CME Group Inc. Names Slate of Director Nominees
• Neutral Sentiment: Analyst/earnings commentary — recent analyst-question coverage from the Q4 call provides context for growth drivers but contains no new guidance. 5 Must-Read Analyst Questions From CME Group’s Q4 Earnings Call
• Negative Sentiment: Short-interest reporting is inconsistent — filings flagged a “significant increase” in February short interest but published data show zeros/NaN, creating ambiguity; if short interest is actually rising, that could add downward pressure.

Analyst Ratings Changes

A number of brokerages have issued reports on CME. Rothschild & Co Redburn lifted their target price on shares of CME Group from $300.00 to $333.00 and gave the company a “neutral” rating in a research note on Thursday. Deutsche Bank Aktiengesellschaft increased their price objective on CME Group from $312.00 to $316.00 and gave the stock a “buy” rating in a report on Thursday, February 5th. Royal Bank Of Canada lifted their price objective on CME Group from $295.00 to $302.00 and gave the company a “sector perform” rating in a research report on Thursday, February 5th. Argus lowered their target price on CME Group from $308.00 to $295.00 in a research note on Friday, October 31st. Finally, Jefferies Financial Group cut their price target on CME Group from $304.00 to $302.00 and set a “buy” rating for the company in a research note on Monday, January 12th. Nine equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $299.53.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.